Health & Medicine
-
Ethiopia Confirms Marburg Virus Outbreak in Jinka Town
The Ethiopian Ministry of Health and the Ethiopian Public Health Institute (EPHI) announced a viral hemorrhagic fever (VHF) outbreak on 12 November…
-
2025–26 Ethiopian Marburg virus disease outbreak
The Ethiopian Ministry of Health and the Ethiopian Public Health Institute (EPHI) announced a viral hemorrhagic fever (VHF) outbreak on 12 November…
-
Marburg Virus Outbreak Hits Remote Ethiopian Market Town Jinka Suddenly
Health officials in Ethiopia have confirmed that a viral hemorrhagic fever affecting the market town of Jinka in the southern highlands is…
-
Pembrolizumab Keytruda Advances Cancer Immunotherapy
United States, September 18, 2025 — cybernewschronicle.com — Pembrolizumab, a humanized monoclonal antibody sold under the brand name Keytruda, has been a…
-
Keytruda Cancer Drug Shows Promising Results Despite Side Effects
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
-
Cholera Epidemic Devastates Sudan, Death Toll Continues to Rise Sharply
The cholera epidemic that began in 2024 has become the most severe outbreak in Sudan in recent years, with the death toll…
-
Sudanese Cholera Epidemic Worsens with Thousands of Reported Cases
The cholera outbreak that erupted in Sudan in 2024 has surged to become the most severe episode of the disease recorded in…
-
CDC Declares 2025 Southwest Measles Outbreak Over
United States, August 22, 2025 — cybernewschronicle.com — The 2025 Southwest United States measles outbreak, which began in January 2025, has been…
-
Measles Outbreak in Southwest US Officially Declared Over Yesterday
The Texas Department of State Health Services announced on August 18 that the 2025 measles outbreak sweeping the Southwest has been declared…
-
Breakthrough Narcolepsy Treatment Shows Promise in Phase 3 Trials Recently
For many years, treatment for narcolepsy has centered on alleviating symptoms rather than correcting the disorder’s root cause. Takeda’s experimental compound, oveporexton,…
-
Takeda’s Oveporexton Shows Promise for Narcolepsy Treatment in Trials Completed
In July 2025, Takeda announced that its experimental wake‑promoting drug, oveporexton, successfully completed phase 3 clinical testing for narcolepsy. The trial results…
-
NYT Probes Ascension Aggressive Medical Debt Collection
A 2022 investigation by The New York Times alleged that Ascension, one of the largest nonprofit Catholic health systems in the United…
-
Ascension Healthcare System Expands Nationwide Across Seventeen US States
Effective July 1, 2025, Ascension—one of the United States’ largest nonprofit Catholic health systems—maintains an extensive presence in 17 states and the…
-
WHO Tracks Nine Variants of SARS-CoV-2 Virus Globally Found
The World Health Organization is monitoring nine distinct versions of the SARS-CoV-2 virus as of June 25, 2025. Some of these versions…
-
Variants of SARS-CoV-2: WHO Monitors Evolution and New Strains as of June 2025
As of June 25, 2025, the World Health Organization (WHO) continues to monitor the evolution of severe acute respiratory syndrome coronavirus 2…
-
FDA Approves Yeztugo, a Groundbreaking New HIV Treatment Option
Gilead Sciences received U.S. Food and Drug Administration clearance for lenacapavir, now marketed as Yeztugo, after clinical trials demonstrated a dramatic reduction…
-
FDA Approves Gilead’s New HIV Treatment Drug Yeztugo Successfully
The U.S. Food and Drug Administration has given the green light to Gilead Sciences’ lenacapavir, which will be sold under the brand…
-
Thailand Reverses Cannabis Policy, Halting Commercial Sales and Growth
Immediate suspension of commercial licences Officials declared that all pending licences for commercial production would be suspended immediately. While the existing legal…
-
Thailand’s Cannabis Industry Halted Due to Public Health Concerns Suddenly
BANGKOK — What began as Southeast Asia’s most ambitious cannabis experiment has come to an abrupt end. On July 25, 2024, Thailand’s…
-
New Weight-Loss Drug Mazdutide Shows Promising Results In Late Trials
A collaborative effort between U.S. drugmaker Eli Lilly and Chinese biotech Innovent Biologics has produced mazdutile, a once‑weekly injectable designed to address…
-
World’s first gonorrhea vaccine programme launches in England
From August, NHS England will roll out a national programme that uses the 4CMenB meningococcal B vaccine to combat gonorrhea, marking the…
-
Eli Lilly Mazdutide Weight Loss Drug Shows Promise
China, May 21, 2025 — infopulsetoday.com — New clinical data released in May 2025 show that the investigational drug mazdutide, a once-weekly…
-
NHS England launches world-first gonorrhea vaccination programme
NHS England is preparing to introduce a vaccination programme targeting gonorrhea, scheduled to begin in August. This initiative is described as the…
-
US Regulators Approve New Moderna COVID-19 Vaccine Mnexspike Version
In May 2025, U.S. regulators granted approval to a revised formulation of the Moderna COVID‑19 vaccine, marketed as Mnexspike (mRNA‑1283). This authorization…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Sugar‑sweetened beverages raise teen anxiety and depression risk, Australian study finds
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
MD Anderson Breakthroughs Advance Immunotherapy for Lung Cancer
-
How Modern Immunotherapy Is Redefining Cancer Treatment Beyond Chemotherapy
-
26% of Americans Spend More Than They Earn as Credit Card Debt Rises and Budgets Tighten
-
How Medicaid Estate Recovery Claims Decedents’ Homes Through Premiums
-
How Insurance Agent Commissions Drive Medicare Advantage Enrollments
-
How Medicare Advantage Plans Hide the 63-Day Medigap Window—and What It Costs You to Miss It
-
How Mortgage Rates Could Shift Over the Next Five Years
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
Theo Burrell’s death sparks renewed calls for brain cancer research funding
-
Timeline of Ellie Sullivan’s Cancer Journey: 2013 to 2026
-
Thousands embrace mud and purpose at Heaton Park Pretty Muddy run.
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds
























